Altimmune GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 win
Altimmune GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 win.
Altimmune
Altimmune is a metabolic / liver disease company. See today's news for the latest developments.
Company Info
Sector:Metabolic / Liver Disease
Headquarters:Gaithersburg, Maryland, USA
Founded:1993
Website:www.altimmune.com/
Upcoming Milestones & Key Dates
2026-07-28
Milestone
Initial profile created
Clinical Development Pipeline
See pipeline
Target: See pipelineRecent News
Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study
Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study.
Altimmune's GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial
Altimmune's GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial
Leadership Team
See company website
Leadership team